Form 4: Twist Bioscience SVP Sells Shares for Tax Obligations

Paula Green, SVP of Human Resources at Twist Bioscience, executed a non-discretionary sale of 619 common shares to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience Corporation (TWST), reported a transaction involving company common stock.
• On August 21, 2025, Ms. Green sold 619 shares of common stock at a price of $25.964 per share.
• This sale was not a discretionary trade but was mandated by Twist Bioscience's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Ms. Green beneficially owns 125,729 shares of Twist Bioscience common stock, which includes shares acquired under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary 'sell to cover' transaction for tax purposes, which is a neutral event and does not reflect positively or negatively on the company's operational or financial performance.

Positives

• The transaction is a 'sell to cover' for tax obligations, indicating the vesting of Restricted Stock Units (RSUs) for an executive, which is a standard component of executive compensation.

Negatives

• No specific negative implications are directly evident from this routine, non-discretionary transaction.

Future Outlook

This filing, a routine insider transaction report, does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

Insider transaction reports (Form 4s) are standard regulatory disclosures for executives and directors of publicly traded companies. 'Sell to cover' transactions are common practice in the industry for managing tax liabilities associated with equity compensation vesting, and are generally not indicative of management's discretionary view on the company's stock.

Stakeholder Impact

• Shareholders: Minimal impact, as it's a routine, non-discretionary sale for tax purposes and not indicative of a change in management's confidence.
• Employees: No direct impact beyond the reporting person.

Key Dates

Keywords

Twist Bioscience, TWST, Insider Transaction, Form 4, Share Sale, Restricted Stock Units, Tax Withholding, Executive Compensation